The Bloom 145 - Flood of Psychedelic Research
The Bloom #145 Free Edition catching up Welcome to all the new readers of The Bloom. This newsletter usually goes out every week, but due to several circumstances it's only hitting your inbox now. This means there is a lot to cover, and instead of the top 3 articles from last week, I've featured 8. Outside of the lab, two more psychedelic companies have received FDA Breakthrough Designation (a fast-track for review, like the one Lykos is currently in the final stages of). Cybin is developing...